Citation 89153

ITO,C: ITOIGAWA,M: MIYAMOTO,Y: ONODA,S: RAO,KS: MUKAINAKA,T: TOKUDA,H: NISHINO,H: FURUKAWA,H:. (2003). POLYPRENYLATED BENZOPHENONES FROM GARCINIA ASSIGU AND THEIR POTENTIAL CANCER CHEMOPREVENTIVE ACTIVITIES.. 66(2)

Citation Details

Title	POLYPRENYLATED BENZOPHENONES FROM GARCINIA ASSIGU AND THEIR POTENTIAL CANCER CHEMOPREVENTIVE ACTIVITIES.
Authors	ITO,C: ITOIGAWA,M: MIYAMOTO,Y: ONODA,S: RAO,KS: MUKAINAKA,T: TOKUDA,H: NISHINO,H: FURUKAWA,H:
Year	2003
Volume	66
Issue	2

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID	ACTIVE

Garcinia assigu (CLUSIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	GARCINOL,ISO: 13-O-METHYL ETHER	None
2	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GARCINOL,ISO: 13-O-METHYL ETHER	ACTIVE
3	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GARCINOL,ISO: 13-O-METHYL ETHER	INACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	GARCINOL-13-O-METHYL ETHER	None
5	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GARCINOL-13-O-METHYL ETHER	ACTIVE
6	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GARCINOL-13-O-METHYL ETHER	INACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATACD SPECTRUM REPORTED FOR	GARCINOL,ISO:	None
8	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GARCINOL,ISO:	ACTIVE
9	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GARCINOL,ISO:	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATACD SPECTRUM REPORTED FOR	GARCINOL	None
11	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GARCINOL	ACTIVE
12	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GARCINOL	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OF	CLUSIANONE	None
14	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLUSIANONE	ACTIVE
15	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CLUSIANONE	INACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MACURIN	None
17	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MACURIN	ACTIVE

Show SPARQL Queries (1)